0 By Sabine Konhaeuser In Press ReleasesPosted April 3, 2024Long-term safety and effectiveness of the Fantom bioresorbable coronary artery scaffold: final results of the FANTOM II trial READ MORE
0 By Tim Ho In Press ReleasesPosted September 27, 2022REVA MEDICAL ANNOUNCES INITIATION OF ENROLLMENT IN THE MOTIV IDE CLINCIAL TRIAL READ MORE
0 By Tim Ho In Press ReleasesPosted August 9, 2022REVA MEDICAL ANNOUNCES CLOSING OF STRATEGIC FINANCING READ MORE
0 By Tim Ho In Press ReleasesPosted June 14, 2022REVA MEDICAL PRESENTS 6-MONTH RESULTS FROM MOTIV BTK PILOT STUDY READ MORE
0 By Tim Ho In Press ReleasesPosted May 24, 2022REVA MEDICAL ANNOUNCES FINAL 5 YEAR RESULTS FOR IT’S FANTOM II CORONARY SCAFFOLD STUDY READ MORE
0 By Tim Ho In Press ReleasesPosted November 8, 2021Shaping the future of vascular stenting – REVA Medical and B. Braun form new Partnership READ MORE
0 By Tim Ho In Press ReleasesPosted March 29, 2021REVA Medical Presents Data from MOTIV BTK Pilot Trial at LINC READ MORE
